Influenza Vaccine

AmeriHealth to cover FluMist due to vaccine shortage

Published in Vaccine Weekly, January 7th, 2004

In response to the reported shortage of injectible flu vaccines, AmeriHealth announced that for the remainder of this flu season, the insurer will expand its coverage of flu vaccines to include the nasal-spray FluMist.

This special accommodation will apply to those individuals for whom FluMist is recommended by the Centers for Disease Control and Prevention (CDC). The CDC, following indications approved by the U.S. Food and Drug Administration, has recommended the use of FluMist for healthy children and adults between the ages of 5 and 49.

G. Fred DiBona, Jr., AmeriHealth chairman, President and chief executive officer, said the company hoped the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2004-01-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry